《復牌公告》尚捷集團(03860.HK)控股權易手予日企EPS HOLDINGS 今復牌
尚捷集團(03860.HK)公布,日本上市公司EPS HOLDINGS擬向執董兼董事會主席陳永啟收購3.75億股,總代價約為3.71億元,銷售價為每股0.988元,較公司停牌前收市價大幅折讓45%。
緊隨買賣完成後,買方及與其一致行動人士於3.75億股股份中擁有權益,佔公司已發行股本總額之75%。根據收購守則規則,要約人須就所有已發行股份作出強制性無條件現金要約,每股現金要約價為0.988元。要約人擬於要約完成後維持已發行股份於主板之上市地位。
同時,公司計劃與合營合夥人Tai Hei成立合營公司,分別持股51%及49%,合營公司將主要在日本及中國從事帕金森綜合症的藥物篩選、褐色脂肪細胞減肥相關的藥物和機能型食品篩選的業務,由自體細胞誘導褐色脂肪細胞用於減肥細胞治療等業務。
此外,董事會建議將公司之英文名稱由「Speed Apparel Holding Limited」更改為「EPS Creative
Health Technology Group Limited」及中文名稱由「尚捷集團控股有限公司」更改為「EPS 創健科技集團有限公司」。
該公司申請今日復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.